(MRSA) De-isolation Procedure

Similar documents
Using Evidence to Develop a Local, Patients with Methicillin-Resistant

Skin and Nasal Decolonization for Adult

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) SCREEN MEDICAL DIRECTIVE

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Approval Signature: Date of Approval: December 6, 2007 Review Date:

Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection.

Joint Commission NPSG 7: 2011 Update and 2012 Preview

Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA

Clinical Research in Antibiotic Resistance

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

MRSA. Information for patients Infection Prevention and Control. Large Print

Infection Prevention & Control Orientation for Housestaff Welcome to Shands at UF!

Hereford Hospitals NHS Trust

MRSA. Information for patients Infection Prevention and Control

Infection Prevention Control Team

Infection Control Manual. Table of Contents

Methicillin Resistant Staphylococcus aureus (MRSA) screening and decolonisation

Infection Control Manual. Table of Contents

MRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke

Personal Hygiene & Protective Equipment. NEO111 M. Jorgenson, RN BSN

MRSA Policy Best Practice Guidelines. Printed copies must not be considered the definitive version. August 2017 Scope. Infection Control Team

Everyone Involved in providing healthcare should adhere to the principals of infection control.

Policy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019

Investigating Clostridium difficile Infections

NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION

Name of Assessor Unit Date. Element Yes No Action Needed

The Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA

IC CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017

Policy for the control and management of patients colonised or infected with Meticillin Resistant Staphylococcus aureus (MRSA)

infection control MRSA Information for patients (Methicillin Resistant Staphylococcus aureus)

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change

Infection Prevention Isolation Precautions Toolkit

Infection Prevention and Control and Isolation Authored by: Infection Prevention and Control Department

ISOLATION PRECAUTIONS AND MANAGEMENT OF MULTIDRUG-RESISTANT ORGANISMS (MDROS) IN LONG-TERM CARE FACILITIES. Evelyn Cook, RN, CIC Associate Director

Trust Policy, Infection Control

MRSA Management of patients with meticillin-resistant staphylococcus aureus. Ref IPC v3. Status: Approved Document type: Procedure

Infection prevention & control

INFECTION CONTROL POLICY DATE: 03/01/01 REVISED: 7/15/09 STATEMENT

LPN 8 Hour Didactic IV Education

MRSA and Nursing homes: Is there a problem and do we need to change our guidelines?

Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases

Vancomycin-Resistant Enterococcus (VRE)

Chapter 10. medical and Surgical Asepsis. safe, effective Care environment. Practices that Promote Medical Asepsis

The Effect of Contact Precautions for MRSA on Patient Satisfaction Scores

The Clatterbridge Cancer Centre. NHS Foundation Trust MRSA. Infection Control. A guide for patients and visitors

MRSA: Help us to help to help you

Routine Practices. Infection Prevention and Control

Methicillin-Resistant Staphylococcus aureus Health and Social Care Act 2010 Contributes to CQC Core Standard Outcome 8

Provincial Surveillance

Infection Prevention and Control Guidelines for Cystic Fibrosis Patients

The Management of Patients with Meticillin Resistant Staphylococcus Aureus Policy (MRSA)

A guide for patients and visitors MRSA. A guide for patients and visitors

ISOLATION TABLE OF CONTENTS STANDARD PRECAUTIONS... 2 CONTACT PRECAUTIONS... 4 DROPLET PRECAUTIONS... 6 ISOLATION PROCEDURES... 7

Reducing the risk of healthcare associated infection

NEW EMPLOYEE ORIENTATION INFECTION PREVENTION AND CONTROL

Patient and Visitor Involvement: The Hand Hygiene Missing Link?

Infection Prevention, Control & Immunizations

Reducing the risk of healthcare associated infection

METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION

Infection Control and Prevention On-site Review Tool Hospitals

Infection Prevention & Exposure Control Online Orientation. Kimberly Koerner RN, BSN Associate Health Nurse

Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings

Transmission Based Precautions (Isolation Guidelines)

Recommendation II. Recommendation I. Who s on Your Team? Recommendation III

Patient & Family Guide. VRE (Vancomycinresistant. Enterococcus)

Replaces: 08/11/16. Formulated: 1/2000 TRANSMISSION-BASED PRECAUTIONS

POLICY FOR TAKING BLOOD CULTURES

Presented by: Mary McGoldrick, MS, RN, CRNI

Emergency Department Isolation Precautions

METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): CONTROL AND PREVENTION

Blood Culture Policy

THE INFECTION CONTROL STAFF

Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care

Infection Control Policy and Procedure Manual. Post-Anesthesia Care Unit (Recovery Room) Page 1 of 6

Disclosure Status (B) B Can be disclosed to patients and the public

ACG GI Practice Toolbox. Developing an Infection Control Plan for Your Office

Prevention and Control of Carbapenem Resistant Enterobacteriaceae Infections

PROCEDURE FOR TAKING A WOUND SWAB

Pulmonary Care Services

Meticillin Resistant Staphylococcus Aureus (MSRA) for Community Settings Policy

The Physician's Role in Controlling MRSA in Healthcare Settings

MRSA Meticillin-resistant

Direct cause of 5,000 deaths per year

Checklists for Preventing and Controlling

2014 Partnership in Prevention Award. November 21, :00-1:00PM EST. Introduction

Prairie North Regional Health Authority: Hospital-acquired infections

Infection Prevention and Control for Phlebotomy

INFECTION CONTROL ORIENTATION TRAINING 2006

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of

Patient Information Service. Infection prevention and control department MRSA

Community Infection Prevention and Control Guidance for Health and Social Care

POLICIES & PROCEDURES. Number: Authorization: SHR Regional Infection Control Committee

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN

Community Infection Prevention and Control Guidance for Health and Social Care

ISOLATION PRECAUTIONS INTRODUCTION. Standard Precautions are used for all patient care situations, but they

Transmission Based Precautions Literature Review: Management of Patient Care Equipment

& PVL Staphylococcus aureus (PVL-SA) Policy

What you can do to help stop the spread of MRSA and other infections

HANDLING AND DELIVERY OF LABORATORY SPECIMENS POLICY

Clinical Director for Women s and Children s Division

Transcription:

Methicillin-Resistant Staphylococcus aureus (MRSA) De-isolation Procedure Updated December 2012 OHSU Department of Infection Prevention and Control Anna Schappacher Brown RN OHSU SON Master of Public Health - Intern

Why was the MRSA de-isolation policy updated? 1 The Infection Prevention and Control Department (IPC) recognizes the burden that isolation places on patients and staff. 2,3,4 The former de-isolation procedure required multiple negative swabs for contact isolation to be removed from a patient s chart. Obtaining multiple swabs and follow-up on culture results was difficult. The new policy has simplified the process to assist health care providers in: Confirming infection and/or colonization of MRSA OR Discontinuing isolation precautions when MRSA is no longer present The new policy will primarily be used by inpatient units and the Emergency Department. The ambulatory units and perioperative departments should also be aware, as they can educate patients regarding the de-isolation procedure.

The new MRSA de-isolation policy requires one set of negative screening cultures from the following anatomical locations Nares Perineum Wound, if present

Why the perineum? Obtaining cultures from both the nares and the perineum increases the chances of correctly identifying which patients have MRSA. 5 In other words, a person may have a negative culture from the nose and a positive culture from the perineum. If only a nasal culture were taken, the person would get a false-negative result. Isolation would be removed when they are in fact MRSA positive. Studies have shown cultures from both nose and perineum detect 93% of MRSA positive patients, which is significantly higher than cultures from other anatomical areas. 5 When explaining this to the patients, you can say: We want to be sure we get an accurate result for your safety and others. Taking a swab from the nose, the perineum and your wound will give us the best chance. If all tests are negative, we can take you off isolation precautions.

Your patient is on MRSA isolation precautions. What should the RN do? Ask: When was the last lab-confirmed MRSA positive culture? If last positive culture was less than 6 months ago, patient is not eligible for de-isolation. If last positive culture was within 6-12 months, keep patient in contact isolation precautions and perform nasal, perineal and wound (if present) screening cultures (instructions to follow). If last positive culture was greater than 1 year ago: is the patient HIGH risk? If the patient is HIGH risk Keep patient in contact isolation and perform nasal, perineal, and wound (if present) screening cultures (instructions to follow). If the patient is NOT HIGH risk Discontinue isolation precautions and call Infection Control (4-6694) to have alert removed from patient s chart.

What makes a patient high risk for MRSA? Chronic indwelling device: tracheostomy, peg tube, foley, central venous catheter, etc. Open wound Hemodialysis Long term care or nursing home resident Hospitalized within past 6 months Current IV drug user Treated with antibiotics within past 48 hours Has a household member with MRSA infection within past 6 months

What happens after the culture results are complete? If ANY culture result is positive for MRSA, keep patient in contact isolation. No further action needed at this time. If ALL culture results are negative (for each culture site): Discontinue contact isolation precautions Call Infection Control (4-6694) to remove isolation alert on patient s chart Note: While you may not be caring for the patient when the results are complete, the intention is for the next healthcare worker (RN or LIP) to report the results. Infection Control relies on healthcare workers reporting of *negative* results to remove isolation alerts.

What if information regarding MRSA infection is verbal only? Continue Contact Precautions & call Infection Control (4-6694) to obtain lab results from other facility. If lab results are obtained, refer to previous instructions based on date of last MRSA culture. If lab results are unavailable, assume patient is MRSA positive. Keep in Contact Isolation Precautions Perform nasal, perineal and wound (if present) screening cultures. DE-ISOLATION ALGORITHM SUMMARIZES INSTRUCTIONS

Algorithm for De-isolation Procedure *High Risk Criteria for MRSA* Chronic indwelling device: tracheostomy, peg tube, foley, central venous catheter, etc. Open wound Hemodialysis LTC facility or nursing home resident Hospitalized within past 6 months Current IV drug abuser Treated with antibiotics within past 48 hours Household member w/mrsa within past 6 months Note: If last MRSA positive culture was less than 6 months ago: patient is not eligible for de-isolation Infection Prevention and Control Department November 2012

How do I order the cultures in Epic? Get order from LIP to perform MRSA screening cultures. Go to Order Entry in Epic: Type isolation. You will see these choices: Choose the MRSA de-isolation order based on last MRSA culture If last positive MRSA culture is greater than 1 year ago AND NOT HIGH risk: Get LIP order to discontinue contact isolation precautions and call IPC to remove alert on patient s chart.

How do I order the cultures in Epic? (cont.) o If last positive MRSA culture was greater than 1 year ago AND the patient is HIGH risk: 48 o Continue contact isolation precautions. Get LIP order to perform nasal, perineal and wound (if present) screening swabs. Selecting the order will print the order labels to affix to culture tube. o If last positive MRSA culture was within 6-12 months ago: o Continue contact isolation precautions. Get LIP order to perform nasal, perineal and wound (if present) screening swabs. Choosing the order will print order labels to affix to culture tube.

How do I obtain the specimen? Explain procedure and rationale for the screening swabs to the patient. Collection swabs: Use 2-3 sterile swab kits with white cap Aerobic, Anaerobic & Fastidious Bacteria (Logistics supplies the kits) Check the expiration date on culture tube to ensure it is not expired (Lab will not accept an expired swab kit!) Wash hands and put on disposable gloves. Peel open the culture swab kit. Do not touch the swab to any other areas. Nares: Swab each nare 2-5 times (clockwise and counterclockwise) with one swab. The process should gently rub across the nasal mucous membranes about ¾ inch into the adult nasal passage to obtain squamous epithelial cells (should not be in posterior nostril, stay anterior). You can apply slight pressure on the outside of the nose with a finger to help ensure good contact. Perineum: For Men: Swab area between scrotum and anus For Women: Swab area between vagina and anus Rotate swab while brushing across perineum, approximately 3 times. Wound: Rotate swab across open wound, approximately 3 times. If more than one wound is present, call Infection Control for instructions(4-6694)

How do I obtain the specimen? (cont.) Return each swab tip to a separate culture tube, making sure tip is in liquid. Break off stick at perforated red line. Twist and secure cap. Place proper label (nares, perineum, wound) on specimen. Place labeled specimens in bag. Remove gloves and perform hand hygiene. Send specimens to Lab Central. Epic & Collecting Specimen: Order should be Culture, MRSA Only, as seen in previous screen shots. *Please indicate the SOURCE (site) in the COLLECTION workflow. Choosing the correct source in Epic will print the anatomical location on lab label. If source is not specified in Epic, write it on label. Identifying the culture site will be important for evaluating results. Thank you!

More than one wound present? Only swab the wound that was positive for MRSA. If no wounds were positive for MRSA: Only culture one wound If more than one wound was positive for MRSA: Culture only one wound that was positive for MRSA More than one wound with purulent drainage: Culture all wounds with purulent drainage In Summary.. Only culture one wound, unless multiple wounds have purulent drainage. In this case, culture all wounds with purulent drainage.

So, you re thinking: This is a lot of work that I don t have time for?!

Simplified Summary & Tips: Follow the De-isolation Algorithm 1. Determine when the last positive MRSA culture was performed. 2. Determine if isolation can be removed or if screening swabs are needed. 3. Get LIP orders for either: Discontinuation of isolation Collection of MRSA screening swabs 4. Enter orders into Epic. 5. Collect screening swabs and send to Lab Central. 6. Call Infection Control (4-6694) with questions AND if isolation alerts can be removed.

Remember. The new de-isolation procedure is actually much simpler than the previous policy. It will be more effective in de-isolating patients, who are NOT MRSA positive. This policy exemplifies the role of RNs at OHSU: Practitioner role Leader Role Scientist Role By following the policy, you will help create a safer environment for your patients, coworkers, hospital staff and the community!

THANK YOU FOR TAKING TIME TO LEARN ABOUT THE NEW MRSA DE-ISOLATION POLICY! Link to Policy https://ohsu.ellucid.com/documents/view/2371 IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT ANNA BROWN Email: browanna@ohsu.edu OR The Infection Prevention and Control Department 503-494-6694

References 1. Criteria for Discontinuing Isolation Precautions (The De-isolation Grid) (2012, December 5). Oregon Health and Sciences University, Infection Control, HC-IC-128-POL. 2. Khan, F.A., Khakoo, R.A., & Hobbs, G.R. (2006). Impact of contact isolation on health care workers at a tertiary care center. American Journal of Infection Control, 34, 408-413. 3. Abad, C., Fearday, A., & Safdar, N. (2010). Adverse effects of isolation in hospitalized patients: A systemic review. Journal of Hospital Infection, 76, 97-102. 4. Saint, S., Higgins, L., Nallamothu, B.K., & Chenoweth, C. (2003, October). Do physicians examine patients in contact isolation less frequently? A brief report. American Journal of Infection Control, 31,6, 354-356. 5. French, G. L. (2009). Methods for screening methicillin-resistant Staphylococcus aureus carriage. European Society of Clinical Microbiology and Infectious Diseases, 15, 10-16. 6. Siegel, J.D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007). The Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf 7. Siegel J. D., Rhinehart E., Jackson M., & Chiarello L. (2006). The Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant Organisms in Healthcare Settings. 8. SHEA/IDSA Practice Recommendation: Strategies to Prevent Transmission of Methicillin-Resistant Staphlyococcus aureus in Acute Care Hospitals. (2008). Infection Control Hospital Epidemiology, 29:S62-S80. 9. Robicsek, A., Beaumont, J. L., & Peterson, L. R. (2009, April 1). Duration of colonization with Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases, 48, 910-913.